Introduction {#s1}
============

In eukaryotic cells, protein function and stability are post-translationally regulated by small and large molecules such as phosphates, carbohydrates, lipids, and small proteins ([@CIT0002]). The post-translational modification of target proteins by small ubiquitin-like modifier (SUMO) is an important regulatory mechanism ([@CIT0040]). The reversible covalent attachment of SUMO to a lysine residue in a target protein is catalysed by E3 SUMO ligases, although conjugation of SUMO to target proteins can occur without the help of an E3 SUMO ligase ([@CIT0040]). As in other eukaryotes, SUMO modification in plants has been implicated in numerous basic cellular processes, such as stress and defence responses, nitrogen metabolism, and the regulation of flowering ([@CIT0014]; [@CIT0019]; [@CIT0021]; [@CIT0030]; [@CIT0029], [@CIT0026]; [@CIT0003]; [@CIT0020]; [@CIT0006]; [@CIT0041]; [@CIT0033]).

AtSIZ1, a Siz/PIAS (SP)-RING-finger protein, regulates plant responses to nutrient deficiency and environmental stresses, and controls vegetative growth and development (Miura *et al.*, [@CIT0029], [@CIT0026], [@CIT0027]; [@CIT0003]; [@CIT0020]; [@CIT0041]; [@CIT0033]; [@CIT0008]; [@CIT0016]; [@CIT0028]). Due to its important roles in a wide range of physiological processes, sumoylation has been the subject of a growing number of studies in the past decades. Recently, two separate studies have identified a significant number of SUMO conjugates using proteomics methods and yeast two-hybrid screening in *Arabidopsis* under non-stress and stress conditions ([@CIT0007]; [@CIT0024]). The results indicate that sumoylation can regulate diverse biological processes, although the functional consequences of this modification have not been fully characterized. Only a few *Arabidopsis* proteins, such as the nitrate reductases NIA1 and NIA2, inducer of CBF expression 1 (ICE1), the R2R3-type transcription factor MYB30, and the SUMO machinery proteins AtSIZ1 and AtSCE1, have been experimentally demonstrated to be sumoylated ([@CIT0025]; [@CIT0033]; [@CIT0043]).

Flowering time is a critical trait in higher plants, as the timing of the transition from the vegetative to the reproductive phase is essential for reproductive success. Several genes are involved in floral induction in *Arabidopsis*, among which that encoding the MADS-box transcription factor flowering locus C (*FLC*) plays an important role in phase transition ([@CIT0035]; [@CIT0038]). The expression of *FLC* is negatively regulated by vernalization and by components of the autonomous pathway ([@CIT0023]; [@CIT0037]). Vernalization-induced histone modifications are mediated by VRN1, VRN2, VRN5, and VIN3 ([@CIT0011]; [@CIT0009]), leading to the repression of *FLC* expression. In addition, FVE, FLD, AtSWP1, and AtCZS, which participate in the autonomous pathway, modulate the histone deacetylation of FLC chromatin ([@CIT0011]; [@CIT0018]), repressing the transcription of the *FLC* gene. *FLC* transcription is also repressed by RNA-binding or processing proteins such as FCA, FY, FPA, FLK, and LD ([@CIT0023]). Two recent reports have shown that FLC transcription is tightly controlled by long non-coding RNAs such as COOLAIR and COLDAIR, although their regulatory roles differ ([@CIT0039]; [@CIT0012]). In addition, *FLC* transcription is positively regulated by FRI and EFS, an *Arabidopsis* PAF1 homologue ([@CIT0011]; [@CIT0017]; [@CIT0042]). Although several factors affecting the transcription of *FLC* have been described, the post-translational regulation of FLC stability and function has not been clearly characterized.

A recent study has shown that FLC is polyubiquitinated by SINAT5 *in vitro* ([@CIT0032]), indicating that its stability may be regulated by a specific E3 ubiquitin ligase. This result suggests that the regulation of the floral transition by FLC involves a post-translational mechanism.

In the present study, it is shown that sumoylation plays a role in the regulation of flowering time by modulating the activity of FLC. AtSIZ1 stabilizes FLC through direct interaction, and it inhibits FLC sumoylation *in vitro*. Overexpression of *mFLC*, a sumoylation site mutant gene, had no effect on flowering time. These findings indicate that FLC is stabilized by the E3 SUMO ligase AtSIZ1, and FLC-mediated flowering repression is stimulated by sumoylation.

Materials and methods {#s2}
=====================

Plant materials and growth conditions {#s3}
-------------------------------------

The wild-type *Arabidopsis thaliana* plants used in this study were of the Columbia-0 (Col-0) ecotype. For plants grown in medium, seeds were surface-sterilized in commercial bleach that contained 5% sodium hypochlorite and 0.1% Triton X-100 solution for 10min, rinsed five times in sterilized water, and stratified at 4 °C for 2 d in the dark. Seeds were planted on agar plates containing Murashige and Skoog (MS) medium, 2% sucrose, and 0.8% agar, buffered to pH 5.7. For plants grown in soil, seeds were directly sown into sterile vermiculite. All plants including seedlings were grown at 22 °C under a 16h light/8h dark cycle in a growth chamber.

Construction of recombinant plasmids {#s4}
------------------------------------

To produce His~6~-FLC, the cDNA encoding full-length FLC was amplified by PCR and inserted into the pET28a vector (Novagen). To produce glutathione *S*-transferase (GST)--AtSIZ1 or its deletion mutants, the cDNAs encoding either the full length or the deletion mutants of AtSIZ1 cDNA were inserted into the pGEX4T-1 vector (Amersham Biosciences). GST--AtSIZ1 (D1), GST--AtSIZ1 (D2), and GST--AtSIZ1 (D3) contained amino acids 90--470, 300--470, and 1--100 of AtSIZ1, respectively. For the maltose-binding protein (MBP)--AtSIZ1-haemagglutinin (HA) fusion, a cDNA encoding full-length AtSIZ1 was amplified by PCR using a primer tagged with HA and inserted into the pMALc2 vector (New England Biolabs).

For His~6~-FLC-Myc and GST--FLC-Myc production, cDNA encoding full-length FLC was amplified by PCR using primers tagged with Myc and inserted into pET28a and pGEX4T-1, respectively.

To produce the FLC mutant proteins GST--FLC(K5R)-Myc, GST--FLC(K135R)-Myc, GST--FLC(K154R)-Myc, and His~6~-FLC(K154R)-Myc (the numbers indicate the positions of the lysines in FLC that were mutated to arginine), GST--FLC-Myc and His~6~-FLC-Myc were subjected to site-directed mutagenesis using overlapping primers ([Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1) available at *JXB* online). The double mutants GST--FLCm1(K5R, K135R)-Myc, GST--FLCm2(K5R, K154R)-Myc, and GST--FLCm3(K135R, K154R)-Myc were also generated by site-directed mutagenesis of GST--FLC(K5R)-Myc, GST-FLC(K135R)--Myc, and GST--FLC(K154R)-Myc using overlapping primers ([Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1)).

The *Arabidopsis* SUMO1 full-length cDNA was amplified by PCR with gene-specific primers and inserted into pET28a to produce the His~6~-AtSUMO1-GG, containing full-length FLC extended with GG at the 3' end. To produce GST--IAA4 (INDOLEACETIC ACID 4), the cDNA encoding full-length IAA4 was amplified by PCR with gene-specific primers and inserted into the pGEX4T-1 vector.

*Arabidopsis* SUMO E1 and E2 enzyme-encoding constructs were kindly provided by Dr H.-P. Stuible ([@CIT0005]).

All constructs were transformed into *Escherichia coli* BL21/DE3 (pLysS) cells. The transformed cells were treated with IPTG (isopropyl-β-[d]{.smallcaps}-thiogalactoside) to induce fusion protein expression.

The sequences of the primers used in this study are listed in [Supplementary Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1) at *JXB* online. All the constructs were verified by automatic DNA sequencing to ensure that no mutations were introduced

Production of transgenic *Arabidopsis* plants {#s5}
---------------------------------------------

To produce FLC- or mFLC (K154R)-overexpressing plants, the corresponding full-length cDNAs were amplified by PCR using a forward primer and a reverser primer tagged with FLAG~3~ and inserted into the plant expression vector pBA002. Recombinant plasmids *35S-FLC-FLAG* ~*3*~ and *35S-mFLC-FLAG* ~*3*~ were introduced into *Arabidopsis* by floral dipping ([@CIT0004]). To produce double transgenic plants, the full-length cDNA encoding AtSIZ1 was amplified by PCR using a forward primer tagged with HA~3~ and a reverser primer and inserted into the plant expression vector pER8. The resulting recombinant plasmids *XVE-HA* ~*3*~ *-AtSIZ1* and *35S-FLC-FLAG* ~*3*~ were also introduced into *Arabidopsis* by floral dipping.

Purification of recombinant proteins {#s6}
------------------------------------

All of the recombinant proteins were expressed in *E. coli* strain BL21 and were purified in accordance with the manufacturer's instructions. Briefly, for His~6~-AtSAE1b, His~6~-AtSAE2, His~6~-AtSCE1, His~6~-AtSUMO1, His~6~-FLC, His~6~-mFLC, His~6~-FLC-Myc, and His~6~-mFLC-Myc purification, bacteria were lysed in 50mM NaH~2~PO~4~ (pH 8.0), 300mM NaCl, 1% Triton X-100, 1mM imidazole, 5mM dithiothreitol (DTT), 2mM phenylmethylsulphonyl fluoride (PMSF), and a proteinase inhibitor cocktail (Roche), and purified on Ni^2+^-nitrilotriacetate (Ni^2+^-NTA) resins (Qiagen). For GST, GST--AtSIZ1 (GS), GST--AtSIZ1 (D1), GST--AtSIZ1 (D2), GST--AtSIZ1 (D3), GST--AtSUMO1, GST--FLC-Myc, GST--mFLC-Myc, GST--FLCm1-Myc, GST--FLCm2-Myc, GST--FLCm3-Myc, and GST--IAA4 purification, bacteria were lysed in PBS buffer (pH 7.5) containing 1% Triton X-100, 2mM PMSF, and a proteinase inhibitor cocktail (Roche), and purified on glutathione resins (Pharmacia). For MBP--AtSIZ1 purification, bacteria were lysed in 20mM TRIS-HCl (pH 7.4), 200mM NaCl, 1mM EDTA, 1% Triton X-100, and 2mM PMSF containing a proteinase inhibitor cocktail (Roche), and purified on amylose resins (New England Biolabs). Protein concentrations were determined by the Bradford assay (Bio-Rad). For MBP--AtSIZ1-HA, bacteria were lysed in 50mM TRIS-HCl pH 7.5, 200mM NaCl, 1% Triton X-100, 5mM dithiothreitol (DTT), 2mM PMSF, and a proteinase inhibitor cocktail (Roche), and purified on amylose resins (New England Biolabs).

*In vitro* binding assay {#s7}
------------------------

To examine the *in vitro* binding of GST--AtSIZ1 to His~6~-FLC, 2 μg of full-length GST--AtSIZ1 or deletion mutant baits and 2 μg of full-length His~6~-FLC prey were added to 1ml of binding buffer \[50mM TRIS-HCl (pH 7.5), 100mM NaCl, 1% Triton X-100, 0.2% glycerol, 0.5mM β-mercaptoethanol\]. After incubation at 25 °C for 2h, the reaction mixtures were incubated with a glutathione resin for 2h before washing six times with buffer \[50mM TRIS-HCl (pH 7.5), 100mM NaCl, 1% Triton X-100\]. Absorbed proteins were analysed by 11% SDS--PAGE and detected by western blotting using an anti-His antibody (Santa Cruz Biotechnology).

To examine the dimerization of the FLC protein, 2 μg of full-length GST--FLC bait and 2 μg of full-length His~6~-FLC or His~6~-mFLC prey were added to 1ml of binding buffer as described above. After incubation at 25 °C for 2h, the reaction mixtures were incubated with a glutathione resin and absorbed proteins were analysed as described above.

For determination of the *in vitro* binding of the FLC mutant protein His~6~-mFLC to MBP--AtSIZ1, 2 μg of full-length MBP--AtSIZ1 bait and 2 μg of full-length His~6~-FLC or His~6~-mFLC prey were added to 1ml of binding buffer as described above. After incubation at 25 °C for 2h, the reaction mixtures were incubated with an amylose resin for 2h before washing six times with buffer \[50mM TRIS-HCl (pH 7.5), 100mM NaCl, 1% Triton X-100\]. Absorbed proteins were analysed as described above.

Sumoylation assays {#s8}
------------------

*In vitro* sumoylation was performed in 30 μl of reaction buffer \[200mM HEPES (pH 7.5), 5mM MgCl~2~, 2mM ATP\] with 50ng of His~6~-AtSAE1b, 50ng of His~6~-AtSAE2, 50ng of His~6~-AtSCE1, 8 μg of His~6~-AtSUMO1-GG, and 100ng of His~6~-FLC-Myc (or GST--FLC-Myc) with or without 500ng of MBP--AtSIZ1-HA. After incubation for 3h at 30 °C, the reaction mixtures were separated on 10% SDS--polyacrylamide gels. Sumoylated His~6~-FLC-Myc or GST--FLC-Myc was detected by western blotting using an anti-Myc antibody (Santa Cruz Biotechnology).

To identify the sumoylation site on FLC, GST--FLCm1-Myc, GST--FLCm2-Myc, GST--FLCm3-Myc, and GST--mFLC-Myc were added to the reaction mixtures instead of His~6~-FLC-Myc or GST--FLC-Myc, respectively. The reaction and the subsequent steps were as described above.

To confirm the identity of the sumoylated FLC band, the sumoylation reaction was performed with GST--AtSUMO1-GG instead of His~6~-AtSUMO1-GG under the reaction conditions described above.

Bimolecular fluorescence complementation of AtSIZ1 and FLC {#s9}
----------------------------------------------------------

To generate constructs for the bimolecular fluorescence complementation (BiFC) protein interaction assay, the cDNAs for AtSIZ1 and FLC were cloned into the pDONR201 vector. Next, the cDNAs for AtSIZ1 and FLC were transferred from their respective entry clones to the gateway vector pSAT4-DEST-n(174)EYFP-C1 (ABRC stock number CD3-1089) or pSAT5-DEST-c(175-end)EYFP-C1(B) (ABRC stock number CD3-1097), which contained the N-terminal 174 amino acids of enhanced yellow fluorescent protein (EYFP^N^) or the C-terminal 64 amino acids of EYFP (EYFP^C^). The fusion constructs encoding nEYFP--SIZ1 and cEYFP--FLC proteins were mixed at a 1:1 ratio and co-bombarded into onion epidermal cells using a helium biolistic gun. Bombarded tissues were incubated at 25 °C in the dark for 16h and YFP signals were observed by confocal laser scanning microscopy.

Effects of AtSIZ1 overexpression on FLC concentration *in vivo* {#s10}
---------------------------------------------------------------

Fourteen-day-old light-grown (16h light/8h dark) plants carrying *35S-FLC-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1* or *35S-mFLC-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1* transgenes on MS medium were treated in the light with or without β-oestradiol for 15h. Samples were ground in liquid nitrogen and lysates were separated by SDS--PAGE. FLC--FLAG~3~ and mFLC--FLAG~3~ levels were examined by western blotting with anti-FLAG antibody. HA~3~-AtSIZ1 induction was analysed by western blotting with anti-HA antibody. Post-translational degradation of FLC was examined using double transgenic plants of *35S-FLC-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1* or *35S-mFLC-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1*. Transgenic plants were incubated in liquid medium with β-oestradiol for 15h for the induction of AtSIZ1 expression, washed, and then transferred to MS medium with 100 μM cycloheximide (CHX). Treated plants were then incubated for 4h. Proteins were extracted at the indicated time points and analysed by western blotting using anti-HA or anti-FLAG antibodies as described above.

Investigation of flowering time {#s11}
-------------------------------

To examine the effect of sumoylation on FLC-mediated flowering, transgenic plants carrying *35S- FLC-FLAG* ~*3*~ or *35S-mFLC-FLAG* ~*3*~ were generated. After selection of *FLC-FLAG* ~*3*~- or *mFLC-FLAG3*-overexpressingtransgenic plants, wild-type (WT) and transgenic plants were grown in soil under long-day conditions (16h light/8h dark). Flowering time was assessed by counting the number of rosette leaves present at the time of appearance of inflorescences or was also determined by counting the days to flowering.

Yeast two-hybrid assays {#s12}
-----------------------

Yeast two-hybrid assay was performed using the GAL4-based two-hybrid system (Clontech). Full-length *AtSIZ1* and *IAA4* cDNAs were cloned into pGAD424 and pGBT8 (Clontech) to generate the constructs *AD-AtSIZ1*and *BD-IAA4*. The constructs were transformed into the yeast strain AH109 with the lithium acetate method. The yeast cells were grown on minimal medium (--Leu/--Trp). Transformants were plated onto minimal medium (--Leu/--Trp/--His) to test the interactions between AtSIZ1 and IAA4.

Results {#s13}
=======

AtSIZ1 physically interacts with FLC {#s14}
------------------------------------

It was recently reported that FLC directly interacts and co-localizes with the *Arabidopsis* E3 ubiquitin ligase SINAT5 in the nucleus ([@CIT0032]). Since the SP-RING motif protein AtSIZ1 also localizes to the nucleus ([@CIT0029]), the possible physical interaction between AtSIZ1 and FLC was examined using a BiFC assay system. *Arabidopsis* FLC tagged with the C-terminus of EYFP and AtSIZ1 tagged with the N-terminus of EYFP were transiently expressed in onion epidermal cells. It is not known to what extent onion cells reflect the situation in *Arabidopsis* cells. Nevertheless, yellow fluorescence was detected ([Fig. 1](#F1){ref-type="fig"}), indicating the direct interaction of these proteins *in vivo*. To confirm the interaction between FLC and AtSIZ1 in an *in vitro* system, pull-down assays were performed by overexpressing the recombinant proteins in *E. coli* and purifying them with affinity columns ([Fig. 2B](#F2){ref-type="fig"}). [Figure 2C](#F2){ref-type="fig"} shows that GST--AtSIZ1, but not GST alone, was able to pull down *Arabidopsis* FLC. Experiments using deletion mutants showed that the N-terminal region containing the SAP domain of AtSIZ1 \[GST--AtSIZ1 (D3)\] interacts with FLC ([Fig. 2C](#F2){ref-type="fig"}). Therefore, these *in vitro* results suggest that the co-localization of FLC and AtSIZ1 in the nucleus probably reflects their direct interaction *in vivo*.

![FLC interacts with AtSIZ1 *in vivo*. The interaction between AtSIZ1 and FLC was examined by a bimolecular fluorescence complementation (BiFC) assay in onion epidermal cells. AtSIZ1 and FLC cDNAs were fused with YFP at the N-terminal (N) and C-terminal (C) ends, respectively. Each combination of YFP(N)/35S--YFP(C)-FLC, 35S-YFP(N)--AtSIZ1/YFP(C), and 35S-YFP(C)--FLC/35S-YFP(N)--AtSIZ1 was introduced into onion epidermal cells by particle bombardment, and fluorescence signals were detected by confocal microscopy. Bar=50 μm.](exbotj_ert383_f0001){#F1}

![Interaction of AtSIZ1 with FLC. (A) Schematic diagram of bait \[GST (G), GST--AtSIZ1 (GS), GST--AtSIZ1 (D1), GST--AtSIZ1 (D2), and GST--AtSIZ1 (D3)\] and prey (His~6~-FLC) proteins. *In vitro* pull-down of FLC with AtSIZ1. (B) His~6~-FLC, full-length AtSIZ1, or its deletion mutants were overexpressed in *E. coli* and purified with Ni^2+^-NTA or glutathione affinity columns. (C) The His~6~-FLC protein was pulled down with full-length AtSIZ1 or its deletion mutant proteins, separated on 11% SDS--polyacrylamide gels, and analysed by western blotting with an anti-His antibody. I, input (His~6~-FLC).](exbotj_ert383_f0002){#F2}

FLC is sumoylated without AtSIZ1 {#s15}
--------------------------------

The direct interaction of FLC and AtSIZ1 indicated by the *in vivo* and *in vitro* results led to the hypothesis that AtSIZ1 may function as an E3 SUMO ligase for FLC. Therefore, the recombinant proteins GST--AtSIZ1-HA~3~ and His~6~-FLC-Myc were produced to determine whether AtSIZ1 is the E3 SUMO ligase for FLC. In the *in vitro* sumoylation experiments, purified His~6~-FLC-Myc was sumoylated in the presence of E1 and E2 activities ([Fig. 3A](#F3){ref-type="fig"}). However, the sumoylation of His~6~-FLC-Myc was not induced by AtSIZ1. It was also tested whether another AtSIZ1-interacting protein, IAA4, could be sumoylated by AtSIZ1 ([Fig. 3B](#F3){ref-type="fig"}). The result showed that IAA4 was not sumoylated under the reaction conditions employed, including the presence of E1, E2, and E3 ([Fig. 3C](#F3){ref-type="fig"}).

![FLC is sumoylated *in vitro*. (A) *Arabidopsis* His~6~-AtSAE1b, His~6~-AtSAE2, His~6~-AtSCE1, MBP--AtSIZ1, His~6~-AtSUMO1, and His~6~-FLC-Myc were overexpressed in *E. coli* and purified with Ni^2+^-NTA, glutathione, and amylose affinity columns, respectively. Sumoylation of His~6~-FLC-Myc was assayed in the presence or absence of E1 (His~6~-AtSAE1b and His~6~-AtSAE2), E2 (His~6~-AtSCE1), E3 (MBP--AtSIZ1), and His~6~-AtSUMO1. After the reaction, sumoylated FLC was detected by western blotting with an anti-Myc antibody. GST--IAA4 was also used for the sumoylation assay as a negative control. (B) AtSIZ1 directly interacts with GST--IAA4 in yeast. Full-length AtSIZ1 and IAA4cDNAs were fused to sequences encoding the Gal4 activation domain (AD) and the Gal4 DNA-binding domain (BD) in pGAD424 and pGBT8, respectively. The constructs were transformed into yeast strain AH109. Each number indicates the yeast cells transformed with a combination of only pGAD424 and pGBT8 vectors or recombinant plasmids. Transformants were plated onto minimal medium --Leu/--Trp or --Leu/--Trp/--His and incubated for 4 d. (C) Sumoylation of GST--IAA4 was assayed using the same reaction conditions as above. After the reaction, IAA4 was detected by western blotting with an anti-GST antibody.](exbotj_ert383_f0003){#F3}

AtSIZ1 inhibits FLC sumoylation {#s16}
-------------------------------

Despite the interaction between AtSIZ1 and FLC shown in [Figs 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, the results indicate that AtSIZ1 has no E3 SUMO ligase activity for FLC ([Fig. 3A](#F3){ref-type="fig"}). Therefore, experiments were carried out to examine whether AtSIZ1 could block or inhibit the sumoylation of FLC. The addition of increasing amounts of AtSIZ1 protein to the reaction mixture resulted in the gradual inhibition of FLC sumoylation ([Fig. 4A](#F4){ref-type="fig"}). However, AtSIZ1 was sumoylated under the reaction conditions used here ([Fig. 4A](#F4){ref-type="fig"}), indicating that AtSIZ1 is active and that it has self-sumoylation activity under the reaction conditions used. Since all purified proteins used in this experiment were dialysed prior to the reaction, to confirm the effect of AtSIZ1 on FLC sumoylation, an equal volume of dialysis buffer was added to the reactions; this buffer had no effect on FLC sumoylation ([Fig. 4B](#F4){ref-type="fig"}). Therefore, these results indicate that FLC sumoylation is blocked by the AtSIZ1 protein.

![FLC sumoylation is blocked by AtSIZ1. (A) The effect of AtSIZ1 on FLC sumoylation was examined. Purified GST--AtSIZ1-HA was added to the reaction mixture at concentrations ranging from 0.1 μg to 1.0 μg. After the reaction, sumoylated FLC and AtSIZ1 were detected by western blotting with anti-Myc and anti-HA antibodies, respectively. (B) The effect of dialysis buffer on FLC sumoylation was also examined.](exbotj_ert383_f0004){#F4}

Identification of sumoylation sites on FLC {#s17}
------------------------------------------

The deduced amino acid sequences of FLC showed three putative sumoylation sites (ΨKXE) located at Lys5 (K5), Lys135 (K135), and Lys154 (K154; [Fig. 5A](#F5){ref-type="fig"}, [B](#F5){ref-type="fig"}). To identify the sumoylation sites on the FLC protein, single or double mutant derivatives were generated with the mutations K154R, K5R/K135R, K5R/K154R, and K135R/K154R. The proteins were overexpressed in *E. coli*, purified with glutathione affinity columns, and used for *in vitro* sumoylation assays. *In vitro* sumoylation with the double mutant proteins GST--FLCm1-Myc (K5R/K135R), GST--FLCm2-Myc (K5R/K154R), GST--FLCm3-Myc (K135R/K154R), and GST--mFLC-Myc (K154R) showed that GST--FLCm1-Myc was sumoylated, whereas GST--FLCm2-Myc, GST--FLCm3-Myc, and GST--mFLC-Myc were not ([Fig. 5C](#F5){ref-type="fig"}). *In vitro* sumoylation assays including the single mutant protein GST--mFLC-Myc (R) showed that this protein was not modified with SUMO ([Fig. 5D](#F5){ref-type="fig"}), indicating that K154 is the principal site of SUMO conjugation on FLC.

![*In vitro* identification of the sumoylation site on FLC. (A) Deduced amino acid sequences of the FLC protein. Three putative sumoylation sites (ΨKXE) identified using the SUMOplot™ Analysis Program are indicated in bold type. (B) Schematic diagram of the recombinant GST--FLC-Myc protein. The MADS-box and putative sumoylation sites (K5, K135, and K154) are indicated. (C and D) *In vitro* sumoylation assays. Recombinant GST--FLC-Myc, GST--mFLC-Myc, GST--FLCm1-Myc, GST--FLCm2-Myc, and GST--FLCm3-Myc were overexpressed in *E. coli* and purified using a glutathione affinity column. The reaction mixture contained E1 (His~6~-AtSAE1b and His~6~-AtSAE2), E2 (His~6~-AtSCE1), E3 (GST--AtSIZ1), and His~6~-AtSUMO1 without (--) or with (+) a substrate protein. The mutant proteins mFLC, FLCm1, FLCm2, and FLCm3 have amino acid substitutions at residues that are predicted to be SUMO conjugation sites in FLC, as indicated. After the reaction, sumoylated FLC protein was detected by western blotting with an anti-Myc antibody.](exbotj_ert383_f0005){#F5}

FLC is stabilized by AtSIZ1 {#s18}
---------------------------

The AtSIZ1--FLC interaction and the inhibition of FLC sumoylation by AtSIZ1 imply that the concentration of FLC may be regulated by the amount of AtSIZ1 present *in vivo*. FLC concentrations were therefore measured in transgenic plants carrying a *35S-FLC-FLAG* ~*3*~ transgene and an oestradiol-inducible *XVE-HA* ~*3*~ *-AtSIZ1* transgene. Induction of the expression of *AtSIZ1* increased the FLC concentrations up to 1.5- and 3.3-fold in two independent transgenic plants, respectively ([Fig. 6A](#F6){ref-type="fig"}). However, the two independent transgenic plants carrying a *35S-mFLC-FLAG* ~*3*~ transgene and an oestradiol-inducible *XVE-HA* ~*3*~ *-AtSIZ1* transgene showed no changes in mFLC concentration in response to *AtSIZ1* induction ([Fig. 6B](#F6){ref-type="fig"}). It may be possible that the transcript levels of *FLC* or *mFLC* can affect the levels of FLC and mFLC proteins in transgenic plants. Thus *FLC* and *mFLC* transcript levels were examined by real-time reverse transcription--PCR (RT--PCR) and quantitative real-time RT--PCR after induction of *AtSIZ1* in *FLC-* or *mFLC*-overexpressing double transgenic plants. The result showed that the transcript levels of *FLC* and *mFLC* were comparable under these conditions ([Fig.6A](#F6){ref-type="fig"}, [B](#F6){ref-type="fig"}; [Supplementary Fig. S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1) at *JXB* online).

![FLC is stabilized by AtSIZ1 *in vivo*. Double transgenic plants of *35S-FLC-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1* (A) or *35S-mFLC (K154R)-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1* (B) were incubated in liquid medium with β-oestradiol for the induction of *AtSIZ1* expression. After incubation for 15h, HA~3~-AtSIZ1, FLC-FLAG~3~, and mFLC-FLAG~3~ levels were assessed by western blotting with anti-HA or anti-FLAG antibodies. Tubulin was used as a loading control. Numbers under lanes indicate relative intensities. Protein levels were normalized to a value of 1.00 for FLC or mFLC levels in the '−' inducer in both panels. RNA concentrations for *FLC-FLAG* ~*3*~ and *mFLC-FLAG* ~*3*~ were determined by real-time RT--PCR using a FLAG primer and a gene-specific primer. For *HA* ~*3*~ *-AtSIZ1*, RNA concentration was measured by real-time RT--PCR using an HA primer and a gene-specific primer. *Tubulin* RNA was used as a loading control. To assess the degradation of FLC, double transgenic plants of *35S-FLC-FLAG* ~*3*~ and *XVE-HA* ~*3*~ *-AtSIZ1* (C) or *35S-mFLC (K154R)-FLAG* ~*3*~and *XVE-HA* ~*3*~ *-AtSIZ1* (D) were incubated in liquid medium with β-oestradiol for the induction of *AtSIZ1* expression, washed, and transferred to MS medium with 100 μM cycloheximide (CHX). At the indicated times, protein was extracted and analysed by western blotting with anti-HA or anti-FLAG antibodies. Tubulin was used as a loading control. FLC or mFLC levels during degradation were also expressed in graph form. The relative protein levels of FLC (E) or mFLC (F) were normalized to numerical values based on a value of 1.0 for the protein levels at 0h using the data shown in both C and D. Open circles indicate FLC (or mFLC) with AtSIZ1 and filled circles indicate FLC (or mFLC) without AtSIZ1.](exbotj_ert383_f0006){#F6}

The effect of AtSIZ1 on FLC decay was examined by treating the transgenic plants described above with CHX to block new protein synthesis. The results showed that the degradation of FLC was delayed in plants co-expressing *AtSIZ1* ([Fig. 6C](#F6){ref-type="fig"}, [E](#F6){ref-type="fig"}). However, the rate of decay of mFLC was not significantly altered by the expression of *AtSIZ1* ([Fig. 6D](#F6){ref-type="fig"}, [F](#F6){ref-type="fig"}).

FLC modification by SUMO is necessary for flowering repression {#s19}
--------------------------------------------------------------

*FLC* overexpression causes late flowering, and FLC mutants are characterized by early flowering in *Arabidopsis* ([@CIT0036]). Based on these known effects of FLC and the present sumoylation data, the effect of sumoylation on the activity of FLC as a repressor of the transition to flowering was next examined. *FLC*- and *mFLC*-overexpressing transgenic *Arabidopsis* plants were generated using *35S-FLC-FLAG* ~*3*~ and *35S-mFLC-FLAG* ~*3*~ constructs, respectively. After selecting homozygous lines ([Supplementary Fig. S2](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1) at *JXB* online), the recombinant protein levels of FLC-FLAG~3~ and 35S-mFLC-FLAG~3~ were first examined and then the transgenic plants were investigated for vegetative growth and flowering time ([Fig. 7A](#F7){ref-type="fig"}, [B](#F7){ref-type="fig"}). The relative flowering time of each transgenic plant was assessed by counting the number of rosette leaves. The number of rosette leaves in WT plants was 14.75±0.71, and that of *mFLC*-overexpressing plants was 14.63±1.16, which was comparable with that of the WT. However, in *FLC*-overexpressing plants, the number of rosette leaves was 30.50±4.68, which represented an \~2-fold increase ([Fig. 7A](#F7){ref-type="fig"}, [C](#F7){ref-type="fig"}). The relative flowering time of each transgenic plant was also determined by counting the days to flowering. The number of days before the appearance of inflorescences in WT plants was 28.65±1.23, and that of *mFLC*-overexpressing plants was 28.07±0.94, which was comparable with that of the WT. However, in *FLC*-overexpressing plants, the number of days before the appearance of inflorescences was 52.31±1.57, which represented an \~1.85-fold increase ([Fig. 7D](#F7){ref-type="fig"}). As a result, the flowering time was significantly delayed in *FLC*-overexpressing *Arabidopsis* plants, while no changes were detected in *mFLC*-overexpressing plants ([Fig. 7C](#F7){ref-type="fig"}, [D](#F7){ref-type="fig"}). However, vegetative growth was not affected in FLC- or mFLC-overexpressing plants ([Fig. 7A](#F7){ref-type="fig"}), suggesting that sumoylation is an important modification for the regulation of FLC function.

![Phenotypes of FLC-overexpressing plants. (A) Vegetative growth and flowering of transgenic plants overexpressing FLC-FLAG~3~ or mFLC-FLAG~3~ were examined. (B) The protein levels of FLC-FLAG~3~ and mFLC-FLAG~3~ were examined by western blotting with anti-FLAG antibody. Tubulin was used as a loading control. (C) Flowering time in transgenic plants was examined by counting the number of rosette leaves. Significant differences were detected between WT and FLC-FLAG~3~-overexpressing plants, whereas WT and mFLC-FLAG~3~-overexpressing plants were almost identical (*P* \< 0.0001, *t*-test, *n*=12). (D) The days to flowering were also determined to be identical (*P* \< 0.0001, *t*-test, *n*=12). In both cases (C and D), bars indicate standard errors.](exbotj_ert383_f0007){#F7}

Mutant FLC can interact with AtSIZ1 and FLC {#s20}
-------------------------------------------

The observation that AtSIZ1 stabilizes FLC but not mFLC suggests that mFLC does not interact with AtSIZ1. Therefore, the possible interaction between AtSIZ1 and mFLC was examined using an *in vitro* pull-down assay. His~6~-FLC, His~6~-mFLC, and full-length MBP--AtSIZ1 were purified with Ni^2+^-NTA or glutathione affinity columns and it was determined whether or not His~6~-FLC or His~6~-mFLC proteins could be pulled down with AtSIZ1. The results showed that AtSIZ1 interacts with both FLC and mFLC ([Fig. 8](#F8){ref-type="fig"}). As *mFLC* overexpression had no effect on flowering time, an experiment was conducted to investigate whether mFLC can form a complex with FLC ([Fig. 7](#F7){ref-type="fig"}). To this end, the recombinant proteins His~6~-FLC, His~6~-mFLC, GST, and GST--FLC were overexpressed in *E. coli*, these proteins were isolated with Ni^2+^-NTA or glutathione affinity columns, and whether His~6~-FLC or His~6~-mFLC proteins could be pulled down with GST or GST--FLC proteins was examined. As shown in [Fig. 9](#F9){ref-type="fig"}, GST--FLC formed a complex with both His~6~-FLC and His~6~-mFLC.

![AtSIZ1 interacts with mFLC (K154R). (A) His~6~-FLC, His~6~-mFLC, and full-length MBP--AtSIZ1 were overexpressed in *E. coli* and purified with Ni^2+^-NTA or amylose affinity columns. The arrowhead indicates MBP--AtSIZ1. (B) His~6~-FLC or His~6~-mFLC proteins were pulled down with full-length MBP--AtSIZ1, separated on 11% SDS--polyacrylamide gels, and analysed by western blotting with an anti-His antibody.](exbotj_ert383_f0008){#F8}

![FLC can form a complex. (A) His~6~-FLC, His~6~-mFLC, GST, and GST--FLC were overexpressed in *E. coli* and purified with Ni^2+^-NTA or glutathione affinity columns. (B) His~6~-FLC or His~6~-mFLC proteins were pulled down with GST or GST--FLC proteins, separated on 11% SDS--polyacrylamide gels, transferred onto PVDF membranes, and detected by western blotting with an anti-His antibody.](exbotj_ert383_f0009){#F9}

Discussion {#s21}
==========

In the present study, it was shown that FLC-mediated flowering repression is activated by sumoylation and that AtSIZ1 stabilizes FLC.

Eukaryotic cells express SP-RING finger proteins, SAP and Miz-finger domain (Siz) proteins, and protein inhibitor of activated STAT (PIAS) proteins ([@CIT0013]). Recently, SIZ1-type proteins with a SP-RING domain were also identified in plants and were shown to be involved in diverse biological processes ([@CIT0015]; [@CIT0031]).

The function and stability of transcription factors are modulated by various post-translational modifications. The conjugation of SUMO (a protein modifier) to a target protein regulates its function and stability. FLC is modified by ubiquitin ([@CIT0032]), indicating that other post-translational modifications, such as sumoylation, may play a role in the regulation of FLC activity. Experiments were therefore carried out to examine whether AtSIZ1 has E3 SUMO ligase activity for FLC. The results of pull-down and BiFC assays showed a strong interaction between FLC and AtSIZ1 ([Fig. 1](#F1){ref-type="fig"}), and *in vitro* sumoylation assays showed that FLC is modified by SUMO ([Fig. 3](#F3){ref-type="fig"}). However, the results showed that the attachment of SUMO to FLC occurred independently of AtSIZ1 *in vitro* ([Figs 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}).

The covalent attachment of SUMO to a lysine residue in the target protein is generally mediated by E3 SUMO ligases. However, direct transfer from the SUMO-conjugating enzyme Ubc9 can occur through at least two ligase-independent mechanisms. First, Ubc9 can directly recognize the sumoylation motif Ψ-K-x-\[D/E\] (Ψ, an aliphatic branched amino acid; x, any amino acid) and conjugate the lysine residue ([@CIT0001]). Secondly, some SUMO substrates contain SUMO-interacting motifs (SIMs) that promote their own conjugation ([@CIT0022]; [@CIT0044]). These SIMs bind to the SUMO moiety to which Ubc9 is attached, thereby increasing its local concentration and facilitating sumoylation. The results of the present study indicate that FLC is sumoylated by one of these mechanisms in the absence of an E3 SUMO ligase.

Since FLC sumoylation was inhibited by AtSIZ1 ([Fig. 4](#F4){ref-type="fig"}), the mechanisms underlying the binding of AtSIZ1 to FLC and its effect on FLC activity and stability were further examined. For this purpose, double transgenic *Arabidopsis* plants were generated through transformation with a *35S-FLC-FLAG* ~*3*~ transgene and an oestradiol-inducible *XVE-HA* ~*3*~ *-AtSIZ1* transgene to examine the effect of AtSIZ1 on the stability of FLC. *AtSIZ1* induction with oestradiol increased the concentration of FLC but not that of mFLC ([Fig. 6A](#F6){ref-type="fig"}, [B](#F6){ref-type="fig"}). Furthermore, *AtSIZ1* overexpression retarded the degradation of FLC, whereas that of mFLC was not affected ([Fig. 6C](#F6){ref-type="fig"}, [D](#F6){ref-type="fig"}). To confirm these results, the biological effect of AtSIZ1 on FLC and mFLC function and stability is also currently being investigated using double transgenic plants that constitutively overexpress AtSIZ1 and FLC or mFLC.

In any case, based on the present findings, these data suggest that AtSIZ1 stabilizes FLC through direct binding to FLC before or after FLC sumoylation *in vivo* ([Supplementary Fig. S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1) at *JXB* online). Furthermore, the inhibitory effect of AtSIZ1 on FLC sumoylation suggests the possible existence of another E3 SUMO ligase for FLC in *Arabidopsis* ([Supplementary Fig. S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1)).

However, there may be many factors affecting FLC conjugation with SUMO *in vivo*. For example, *in vivo* concentrations of proteins comprising the sumoylation machinery, including *Arabidopsis* SUMO-activating enzyme E1 (SAE1+2) and conjugating enzyme E2 (AtUBC9), AtSUMO, and AtSIZ1, may differ from the concentrations of the proteins used in the *in vitro* system used here, and the expression of each of these components may vary according to developmental stage, thereby affecting FLC sumoylation. In addition, AtSIZ1 can form complexes with various proteins *in vivo* ([@CIT0031]), which affects AtSIZ1 conformation and activity, and, thus, FLC sumoylation. In addition, the timing and localization of *FLC* expression can also be controlled by changes in chromatin structure through histone modifications and DNA methylation ([@CIT0010]). FLC can form complexes with other proteins as well, which can lead to changes in FLC concentration and conformation, thereby leading to increases or decreases in the sumoylation of this protein. Therefore, the possibility that AtSIZ1 enhances FLC sumoylation as an E3 SUMO ligase *in vivo* still cannot be ruled out.

Since FLC is a central regulator of flowering, extensive research has been conducted to elucidate the mechanisms regulating FLC expression at the transcriptional and post-transcriptional levels in association with flowering time ([@CIT0011]; [@CIT0017]; [@CIT0042]; [@CIT0018]; [@CIT0009]; [@CIT0032]; [@CIT0039]; [@CIT0012]). In the present study, the role of FLC in the transition to flowering was examined using the sumoylation site mutant mFLC. To characterize the function of FLC in the control of flowering time, *FLC*- or *mFLC*-overexpressing transgenic *Arabidopsis* plants were generated and their flowering time was examined by counting the number of rosette leaves. *FLC* overexpression delayed flowering, whereas *mFLC* overexpression had no notable effect on flowering time ([Fig. 7A](#F7){ref-type="fig"}, [B](#F7){ref-type="fig"}), indicating that sumoylation is critical for FLC to exert its floral repressor function.

The lack of an effect of *mFLC* overexpression on flowering time may have resulted from an impaired interaction of mFLC with AtSIZ1 or a defect in complex formation with FLC. However, *in vitro* pull-down analysis showed that mFLC interacted with AtSIZ1 and with FLC. From these results, several possible mechanisms explaining why *mFLC* overexpression does not affect flowering time are proposed. First, sumoylation of the FLC protein may be necessary for its activation. As mFLC cannot be modified with SUMO, this protein may not have an effect on flowering time despite its overexpression. Secondly, mFLC may inactivate endogenous FLC. Transgenic mFLC may form a complex with endogenous FLC and act in a dominant-negative form. Thus, a possible reason for the observation that flowering time in *mFLC*-overexpressing plants is comparable with that of WT plants is that the FLC level is originally low in WT plants, although this protein could be scavenged by the overexpressed mFLC through complex formation.

It is believed that if sumoylated FLC can be detected *in vivo*, it may also be possible to find an answer for why *FLC* overexpression delayed flowering, whereas *mFLC* overexpression had no effect on flowering time. However, to date, it has not been possible to detect sumolyated protein *in vivo*, perhaps due to its low level or presence at specific stages. Recently, [@CIT0034] showed that endogenous FLC can be detected by western blot analysis with anti-FLC antibody, but the FLC band intensities were quite weak, even in C24 WT plants. It is well known that FLC protein levels are much lower in the Col background than in the C24 background. Thus, there appear to be specific challenges in detecting FLC in the Col background using antibodies. Production of a specific anti-FLC antibody which works well *in vivo* will be a solution.

DET1 (De-etiolated 1), a SINAT5-interacting partner, blocks the ubiquitination of LHY (Long Hypocotyl) by SINAT5 through direct interaction with SINAT5 ([@CIT0032]). The present data show that AtSIZ1 inhibits the sumoylation of FLC through direct interaction with FLC *in vitro* ([Fig. 4](#F4){ref-type="fig"}). However, AtSIZ1 increased the level of FLC in transgenic plants ([Fig. 6A](#F6){ref-type="fig"}). Furthermore, the degradation of FLC was delayed in the presence of AtSIZ1 ([Fig. 6C](#F6){ref-type="fig"}). These findings suggest that direct binding of AtSIZ1 to FLC protects the protein from degradation induced by its ubiquitination by SINAT5, as shown for DET1, which blocks the ubiquitination of LHY by SINAT5. AtSIZ1 may thus have a protective effect on FLC by antagonizing its ubiquitination ([Supplementary Fig. S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1) at *JXB* online).

In conclusion, the present results indicate that AtSIZ1 controls the stability of FLC by directly binding to FLC, but not through its E3 SUMO ligase activity, and that the FLC-mediated floral transition is negatively regulated by SUMO conjugation. In addition, it was shown that proteolytic turnover of flowering-associated proteins can be regulated by sumoylation. The biochemical mechanisms underlying the regulation of FLC function and stability by sumoylation were also elucidated. Together with previous findings, the data suggest that both of the post-translational modification systems, ubiquitination and sumoylation, can regulate flowering by direct modulation of FLC stability and activity.

Supplementary data {#s22}
==================

Supplementary data are available at *JXB* online.

[Figure S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1). The effect of AtSIZ1 on *FLC* transcript levels.

[Figure S2](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1). Selection of FLC- and mFLC-overexpressing plants.

[Figure S3](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1). Possible regulatory modes of FLC stability.

[Table S1](http://jxb.oxfordjournals.org/lookup/suppl/doi:10.1093/jxb/ert383/-/DC1). List of primers used for this study.
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BiFC

:   bimolecular fluorescence complementation

CHX

:   cycloheximide

DTT

:   dithiothreitol

EYFP

:   enhanced yellow fluorescent protein

GST

:   glutathione *S*-transferase

HA

:   haemagglutinin

IAA4

:   indoleacetic acid 4

IPTG

:   isopropyl-β-[d]{.smallcaps}-thiogalactoside

PMSF

:   phenylmethylsulphonyl fluoride

SUMO

:   small ubiquitin-related modifier

XVE

:   estradiol-inducible promoter.
